---
title: "Artivion to Participate in Upcoming Investor Conferences | AORT Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294107919.md"
description: "Artivion, Inc. (NYSE: AORT) announced it will participate in two upcoming investor conferences. Management will present at the Canaccord Genuity 46th Annual Growth Conference on August 12, 2026, with a live webcast available. Additionally, executives will attend meetings at the Needham Virtual MedTech & Diagnostics 1x1 Conference on August 11, 2026, though no webcast will be provided for this event."
datetime: "2026-07-28T12:10:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294107919.md)
  - [en](https://longbridge.com/en/news/294107919.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294107919.md)
generator: "portal-rs"
---

# Artivion to Participate in Upcoming Investor Conferences | AORT Stock News

, /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences.

Artivion's management team will present at the upcoming Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026 at the InterContinental Boston Hotel. The Company's presentation is scheduled to begin at 9:30 a.m. ET. A live webcast can be accessed through Artivion's website, www.artivion.com, on the Investors page. An archived copy of the webcast will be available for 90 days on the same website. 

Artivion management will also be participating in investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 11, 2026. Due to the format of this event no webcast will be available.

**About Artivion, Inc.**

Headquartered in suburban Atlanta, Georgia, Artivion, Inc., is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.Artivion.com.

**Contacts:**

| **Artivion**              | **Gilmartin Group LLC** |
| ------------------------- | ----------------------- |
| Lance A. Berry            | Brian Johnston          |
| Executive Vice President, | Phone: 332-895-3222     |
| Chief Operating Officer & | investors@artivion.com  |
| Chief Financial Officer   |                         |
| Phone: 770-419-3355       |                         |

SOURCE Artivion, Inc.

### Related Stocks

- [AORT.US](https://longbridge.com/en/quote/AORT.US.md)

## Related News & Research

- [Artivion SVP Regulatory and Quality Andrew M. Green disposes of USD 286,655.6 in common shares](https://longbridge.com/en/news/298771785.md)
- [Artivion SVP Regulatory and Quality Andrew M. Green disposes of USD 216,479 common shares](https://longbridge.com/en/news/298065550.md)
- [Kite Realty Group to Present at the BofA Securities 2026 Global Real Estate Conference | KRG Stock News](https://longbridge.com/en/news/298766715.md)
- [Warby Parker Announces Participation in the Goldman Sachs 33rd Annual Global Retailing Conference | WRBY Stock News](https://longbridge.com/en/news/298364500.md)
- [Cellectis to Host Conference Call and Webcast on September 14 to Provide a Business Update | CLLS Stock News](https://longbridge.com/en/news/298767788.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**